Spain gives go ahead to research using therapeutic cloning
By Typically Spanish,
Typically Spanish
| 01. 24. 2008
The Spanish Commission for the Control of the Donation and Use of Human Stem Cells, a body which depends on the Ministry for Health and Consumer Affairs, has given the green light to the first project in Spain which will use the technique known as nucleus transfer. This is therapeutic cloning to obtain lines of stem cells which are prepared specifically from the patient.
The research is led by Miodrag Stojkovic at the Centro Prínciple Felipe de Valencia, and is intended to investigate the molecular bases of two neurological illnesses, child epilepsy and hereditary palsy. Stojkovic was the first European scientist who managed to clone a human embryo from embryonic stem cells.
The Ministry for Health has also given its support to two other studies, one in Valencia and another in Madrid, but the final approval still has to be obtained from the regional governments in each region.
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...
